PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

NIH-created toxin can kill HIV-infected cells that persist despite treatment

Approach could potentially be part of future HIV cure strategy

2014-01-10
(Press-News.org) Contact information: aura S. Leifman
sivitzl@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
NIH-created toxin can kill HIV-infected cells that persist despite treatment Approach could potentially be part of future HIV cure strategy A team including University of North Carolina and NIH scientists has demonstrated in a mouse model that an HIV-specific poison can kill cells in which the virus is actively reproducing despite antiretroviral therapy. According to the researchers, such a targeted poison could complement antiretroviral therapy, which dramatically reduces the replication of HIV in infected cells but does not eliminate them.

The 40 mice in the experiment were bioengineered to have a human immune system. They were infected with HIV for several months and then given a combination of antiretroviral drugs for four weeks. Half of the animals subsequently received a two-week dose of a genetically designed, HIV-specific poison, or immunotoxin, to complement the antiretrovirals, while the other half continued receiving antiretrovirals alone. The scientists found that, compared to antiretrovirals alone, the addition of the immunotoxin significantly reduced both the number of HIV-infected cells producing the virus in multiple organs and the level of HIV in the blood. According to the researchers, these findings, coupled with results from previous studies, suggest that treating certain HIV-infected people with a combination of antiretrovirals and an immunotoxin might help achieve sustained disease remission, in which HIV can be controlled or eliminated without a lifetime of antiretroviral therapy. However, further study is required, the scientists write.

The immunotoxin, known as 3B3-PE38, was created in 1998 in the laboratories of Edward A. Berger, Ph.D., of the National Institute of Allergy and Infectious Diseases, and Ira Pastan, Ph.D., of the National Cancer Institute, both part of NIH. This genetically modified bacterial toxin targets HIV-infected cells and becomes internalized by them, shutting down protein synthesis and triggering cell death. The study was designed by Drs. Berger and Pastan in collaboration with J. Victor Garcia, Ph.D., and colleagues at the University of North Carolina School of Medicine, where the experiments were performed.

###

ARTICLE: PW Denton et al. Targeted cytotoxic therapy kills persisting HIV-infected cells during ART. PLOS Pathogens DOI: ppat.1003872 (2014).

NIAID Director Anthony S. Fauci, M.D., and Edward A. Berger, Ph.D., senior investigator in the NIAID Laboratory of Viral Diseases, are available for comment.

CONTACT: To schedule interviews, please contact Laura S. Leifman, (301) 402-1663, sivitzl@niaid.nih.gov.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.

NIH...Turning Discovery Into Health®

END



ELSE PRESS RELEASES FROM THIS DATE:

Researchers develop tool to determine individual risk of prostate cancer overdiagnosis

2014-01-10
Researchers develop tool to determine individual risk of prostate cancer overdiagnosis Nomogram aims to enable informed decision-making and personalized treatment SEATTLE - Studies have found that prostate cancer is overdiagnosed in up to 42 percent ...

Study: Athlete's first reaction in victory is dominance

2014-01-10
Study: Athlete's first reaction in victory is dominance Body language, also called 'triumph,' stronger in victors from cultures that emphasize hierarchy SAN FRANCISCO -- Upon victory, an athlete's initial and instinctive reaction is one that displays dominance ...

Researchers pursuing arthritis protein

2014-01-10
Researchers pursuing arthritis protein Chronic inflammation poses something of a mystery for researchers. If we become infected, the body immediately takes steps to repair and tidy it up. This process manifests itself as inflammation, which stems from a high ...

Drought and downing equal vulture supermarkets

2014-01-09
Drought and downing equal vulture supermarkets NEW YORK (EMBARGO: Wednesday, January 8, 2014 5 PM EST, USA) African vultures are famous for quickly finding carcasses; so much so that they are considered clairvoyants in parts of Africa. But just how do vultures ...

UCLA life scientists, colleagues differentiate microbial good and evil

2014-01-09
UCLA life scientists, colleagues differentiate microbial good and evil To safely use bacteria in agriculture to help fertilize crops, it is vital to understand the difference between harmful and healthy strains. The bacterial genus Burkholderia, ...

Elephant shark genome provides new insights into bone formation and adaptive immunity in humans

2014-01-09
Elephant shark genome provides new insights into bone formation and adaptive immunity in humans A*STAR-led international consortium completely decodes the first shark-family member genome 1. Singapore, Jan, 09, 2014 ...

Researchers discover how vascular disease activates autoimmune disorders

2014-01-09
Researchers discover how vascular disease activates autoimmune disorders The hardening of the arteries, also called atherosclerosis, that can lead to heart attack or stroke. has also been linked to autoimmune disorders. It has not been clear why these diseases are related, ...

JCI early table of contents for Jan. 9, 2014

2014-01-09
JCI early table of contents for Jan. 9, 2014 Engineered anti-toxin antibodies improve efficacy The effectiveness of toxin-neutralizing antibodies is considered to be mediated through the interaction of the variable region of the antibody and the toxin; ...

Engineered anti-toxin antibodies improve efficacy

2014-01-09
Engineered anti-toxin antibodies improve efficacy The effectiveness of toxin-neutralizing antibodies is considered to be mediated through the interaction of the variable region of the antibody and the toxin; however, recent studies suggest that the constant ...

Mice exposed to retinoid deficiency in utero exhibit bronchial hyperresponsiveness as adults

2014-01-09
Mice exposed to retinoid deficiency in utero exhibit bronchial hyperresponsiveness as adults Individuals with asthma and COPD are subject to debilitating bronchospasm as a result of airways that are hyperresponsive to stimuli. Factors that lead to the ...

LAST 30 PRESS RELEASES:

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

[Press-News.org] NIH-created toxin can kill HIV-infected cells that persist despite treatment
Approach could potentially be part of future HIV cure strategy